1Trouseau A,Phleglmasta AD. Lectueson clinical medicine,delivered at the Hotel Dieu Paris[M].London:New Sydenham Society,1872.281-295.
2Monreal M,Prandoni P. Venous thromboembolismasa first manifestation of cancer[J].Seminars in Thrombosis and Hemostasis,1999,(02):131-136.doi:10.1055/s-2007-994914.
5Goad KE,Gralnick HR. Coagulations disorders in cancer[J].Hematology/Oncology Clinics of North America,1996,(02):457-484.doi:10.1016/S0889-8588(05)70347-6.
7Monreal M,Lafoz E,Casals A. Occult cancer in patients with deep venous thrombosis[J].Cancer,1991,(02):541-545.doi:10.1002/1097-0142(19910115)67:2<541::AID-CNCR2820670237>3.0.CO;2-J.
8Cornuz J,Pearson SD,Creager MA. Importance of findings on the initial evaluation of cancer in individual with symptomatic idiopathic deep venous thrombosis[J].Annals of Internal Medicine,1996,(10):785-793.
9Pineda LA,Hathwar VS,Grant BJ. Clinical suspicion of fatal pulmonary embolism[J].CHEST,2001,(03):791-805.doi:10.1378/chest.120.3.791.
8[1]Baron JA,Gridley G,Weiderpass E,et al.Venous thromboembolism and cancer[J]. Lancet,1998,351(9109):1077-1080.
9[2]Dintenfass L. Hemorheology of cancer metastasis; An example of malignant melanoma survival time and abnormality of blood viscosity of factors[J].Clin Hemorheol,1992, 12(2):259-271.
10[3]Kubota T, Andoh K, Sedakata H, et al. Tissue factor released from leukemic cell[J]. Thromb Haemostas,1991,65(1):59-63.
6Eitzman DT, Westrick RJ, Shen Y, et al. Homozygosity for fac- tor V Leiden leads to enhanced thrombosis and atherosclerosis in mice [J]. Circulation, 2005, 111 (14): 1822-1825.
7Ewa PG, Manuelle V, Olivier C, et al. Paraneoplastic acral vascular syndrome: Epidemiologic features, clinical manifesta- tions, and disease sequelae [J]. Am Acad Dermatol, 2002, 47: 47-52.
8Donati MB. Cancer and thrombosis [J]. Heamostasis, 1994, 24: 128-131.
9Monreal M, Prandoni P. Venous thromboembolismasa first manifestation of cancer [J]. Semin Thromb Hemost, 1999, 25 (2): 131-136.
